statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agile Therapeutics, Inc. (NASDAQ:AGRX  Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 361,300 shares, a...

Agile Therapeutics, Inc. (NASDAQ:AGRX) Short Interest Update

Q4 2023 Agile Therapeutics Inc Earnings Call Transcript

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Agile Therapeutics reports Q4 EPS ($1.51) vs (10c) last year

Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript...

Agile Therapeutics, Inc. (AGRX) Q4 2023 Earnings Call Transcript

Agile Therapeutics Q4 2023 Earnings Preview...

Agile Therapeutics Q4 2023 Earnings Preview

Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday.
read more...

Why Agile Therapeutics (AGRX) Stock Is Down 60%

PRINCETON, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ( Agile Therapeutics or the Company ), a women's healthcare company, today announced that the Company...

Agile Therapeutics Announces Delisting from Nasdaq

Companies Reporting Before The Bell
 Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million.
read more...

Earnings Scheduled For March 22, 2024

Live Conference Call and Webcast at 8:30 a.m. ETPRINCETON, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will...

Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

Volume	42,214.00
52-Wk High	$7.00
52-Wk Low	$0.20

AGRX Agile Therapeutics Inc

About

Feed

News

Earnings

Fundamentals